1. Home
  2. TRDA vs GRVY Comparison

TRDA vs GRVY Comparison

Compare TRDA & GRVY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TRDA

Entrada Therapeutics Inc.

HOLD

Current Price

$14.19

Market Cap

481.6M

Sector

Health Care

ML Signal

HOLD

Logo GRAVITY Co. Ltd. American Depository Shares

GRVY

GRAVITY Co. Ltd. American Depository Shares

HOLD

Current Price

$61.00

Market Cap

431.2M

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRDA
GRVY
Founded
2016
2000
Country
United States
South Korea
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
481.6M
431.2M
IPO Year
2021
2005

Fundamental Metrics

Financial Performance
Metric
TRDA
GRVY
Price
$14.19
$61.00
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$21.00
N/A
AVG Volume (30 Days)
162.5K
17.2K
Earning Date
05-07-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$25,421,000.00
N/A
Revenue This Year
$39.97
N/A
Revenue Next Year
$50.80
N/A
P/E Ratio
N/A
$8.05
Revenue Growth
N/A
N/A
52 Week Low
$4.93
$54.54
52 Week High
$14.36
$74.75

Technical Indicators

Market Signals
Indicator
TRDA
GRVY
Relative Strength Index (RSI) 61.47 44.29
Support Level $10.84 $60.05
Resistance Level N/A $64.83
Average True Range (ATR) 0.75 1.54
MACD 0.12 0.02
Stochastic Oscillator 87.79 24.95

Price Performance

Historical Comparison
TRDA
GRVY

About TRDA Entrada Therapeutics Inc.

Entrada Therapeutics Inc is a clinical-stage biopharmaceutical company. It aims to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient intracellular delivery into a variety of organs and tissues, resulting in an improved therapeutic index and protein-based programs for the potential treatment of neuromuscular and ocular diseases, among others. Its oligonucleotide programs are in development for the potential treatment of people living with Duchenne, which are exon 44, 45, 50, and 51 skipping amenable. It has partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1.

About GRVY GRAVITY Co. Ltd. American Depository Shares

GRAVITY Co Ltd is an online and mobile games developer and publisher based in Korea. Its principal product, Ragnarok Online, is an online game which is available in more than 91 markets. Its games include Ragnarok Online, Requiem, Dragonica (Dragon Saga), Ragnarok Online II, Requiem Online, and R.O.S.E. Online. The company generates revenue from online games, mobile games and other sources including character based merchandise and animation.

Share on Social Networks: